Evidence map›Paper›PMID 23327665›Full record

ArticleMalaria journal2013

Measurement of Plasmodium falciparum transmission intensity using serological cohort data from Indonesian schoolchildren.

Michael T Bretscher, Supargiyono Supargiyono, Mahardika A Wijayanti, Dian Nugraheni, Anis N Widyastuti, Neil F Lobo, William A Hawley, Jackie Cook, Chris J Drakeley

Open access · goldAbstract read
In one paragraph

Article in Malaria journal, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed
7.5field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

32 citing papers in PubMed, 49 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Serology reveals comparable patterns in the transmission intensities ofFrontiers in cellular and infection microbiology · 2025
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Evaluation of Immunoglobulin G Responses toThe American journal of tropical medicine and hygiene · 2017
    Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 6 institutions in 4 countries.

Michael T BretscherDepartment of Immunology & Infection, London School of Hygiene and Tropical Medicine, London W1CE 7HT, UK. michael.bretscher@lshtm.ac.uk
Supargiyono Supargiyono
Mahardika A Wijayanti
Dian Nugraheni
Anis N Widyastuti
Neil F Lobo
William A Hawley
Jackie Cook
Chris J Drakeley
Universitas Gadjah Mada · IDKarolinska Institutet · SELondon School of Hygiene & Tropical Medicine · GBUniversity of London · GBUniversity of Notre Dame · USWWF-Indonesia · ID

Funding

Wellcome Trust 091924
6 · The paper itself

Abstract

backgroundAs malaria transmission intensity approaches zero, measuring it becomes progressively more difficult and inefficient because parasite-positive individuals are hard to detect. This situation may arise shortly before achieving local elimination, or during surveillance post-elimination to prevent reintroduction. Antibody responses against the parasite last longer than the infections themselves. This "footprint" of infection may thus be used for assessing transmission intensity. A statistical approach is presented for measuring the seroconversion rate (SCR), a correlate of the force of infection, from individual-level longitudinal data on antibody titres in an area of low Plasmodium falciparum transmission.

methodsBlood samples were collected from 160 Indonesian schoolchildren every month for six months. Titres of antibodies against AMA-1 and MSP-1(19) antigens of P. falciparum were measured using ELISA. The distribution of antibody titres among seronegative and -positive individuals, respectively, was estimated by comparing the titres from the study data (a mixture of both seropositive and -negative individuals) with titres from a (unexposed) negative control group of Indonesian individuals. Two Markov-Chain models for the transition of individuals between serological states were fitted to individual anti-PfAMA-1 or anti-PfMSP-1 titre time series using Bayesian Markov-Chain-Monte-Carlo (MCMC). This yielded estimates of SCR as well as of the duration of seropositivity.

resultsA posterior median SCR of 0.02 (Pf AMA-1) and 0.09 (PfMSP-1) person(-1) year(-1) was estimated, with credible intervals ranging from 1E-4 to 0.2 person(-1) year(-1). This level of transmission intensity is at the lower range of what can reliably be measured with the present study size. A Bayesian test for seroconversion of an individual between two observations is presented and used to identify the subjects who have most likely experienced an infection. Furthermore, the theoretical limits of measuring transmission intensity, and how these depend on duration and size of a study as well as on transmission intensity itself, is illustrated.

conclusionsThis analysis shows that it is possible to measure SCR's from individual-level longitudinal data on antibody titres. In addition, individual seroconversion events can be identified, which can be useful in assessing interruption of transmission. Analyses of further serological datasets using the present method are required to improve and validate it. This includes measurement of the duration of antibody responses, how it depends on host age or cumulative exposure, or on the particular antigen used.

Indexed as

Antibodies, ProtozoanAntigens, ProtozoanChildCross-Sectional StudiesEnzyme-Linked Immunosorbent AssayFemaleHumansIncidenceIndonesiaMalaria, FalciparumMaleMembrane ProteinsMerozoite Surface Protein 1Protozoan ProteinsSeroepidemiologic StudiesAntibodies, ProtozoanAntigens, Protozoanapical membrane antigen I, PlasmodiumMembrane ProteinsMerozoite Surface Protein 1Protozoan Proteins

Identifiers

PMID23327665
PMCPMC3605132
OpenAlexW2112614942

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.